KRAS and cancer: Furthermore, in intact mouse allographs, melanoma cells expressing a constitutively active K-Ras mutant possess more rounded shape (68), whereas inhibiting the K-Ras signaling in the same melanoma cells alters the cancer cell morphology to a more elongated shape (68).